Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Breast Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00706030
What this trial is testing

Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer

Who this might be right for
Breast CancerAdvanced Malignant Solid Tumors
Puma Biotechnology, Inc. 92
Not applicableWithdrawnNCT03563352
What this trial is testing

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

Who this might be right for
Breast CarcinomaCholangiocarcinomaColorectal Carcinoma+4 more
University of Southern California
Testing effectiveness (Phase 2)Looking for participantsNCT04348747
What this trial is testing

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Triple-Negative Breast Carcinoma+1 more
Roswell Park Cancer Institute 23
Early research (Phase 1)Ended earlyNCT03955640
What this trial is testing

Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences

Who this might be right for
Metastatic Malignant Neoplasm in the Chest WallRecurrent Breast Carcinoma
Thomas Jefferson University 3
Testing effectiveness (Phase 2)UnknownNCT02983071
What this trial is testing

G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Carcinoma, Ductal, BreastBreast CancerBreast Neoplasm
G1 Therapeutics, Inc. 102
Not applicableStudy completedNCT03284008
What this trial is testing

Assessing Efficacy of Axillary Web Syndrome Treatment

Who this might be right for
Axillary Web Syndrome
European Institute of Oncology 60
Early research (Phase 1)Looking for participantsNCT04222413
What this trial is testing

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Pancreatic CancerPediatric Solid Tumor+3 more
National Cancer Institute (NCI) 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT05554380
What this trial is testing

Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
National Cancer Institute (NCI) 33
Testing effectiveness (Phase 2)UnknownNCT06006390
What this trial is testing

CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+4 more
Chongqing Precision Biotech Co., Ltd 60
Large-scale testing (Phase 3)UnknownNCT04646564
What this trial is testing

Radiotherapy for Extracranial Oligometastatic Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Chinese Academy of Medical Sciences 170
Not applicableStudy completedNCT03868514
What this trial is testing

Post Market Clinical Follow Up to "Patient Reported Outcome" Using a Titanised Polypropylene Mesh (TiLOOP® Bra Pocket)

Who this might be right for
Breast Reconstruction After MastectomyBreast NeoplasmBreast Cancer+1 more
pfm medical gmbh 313
Very early researchEnrolling By InvitationNCT07023848
What this trial is testing

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

Who this might be right for
Breast CancerGastric Cancer (GC)Urothelial Carcinoma (UC)
Affiliated Hospital of Jiangnan University 10
Not applicableStudy completedNCT04343807
What this trial is testing

Effectiveness of Ultrasound Guided PECS Block on Opioid Consumption and Patient Satisfaction Through Adequate Pain Control Following Breast Cancer Surgery.

Who this might be right for
Breast Neoplasm FemalePain, PostoperativePain+3 more
Aga Khan University 70
Not applicableStudy completedNCT00659906
What this trial is testing

Optimizing Body Composition & Health After Breast Cancer

Who this might be right for
Breast NeoplasmOsteoporosis, Postmenopausal
OHSU Knight Cancer Institute 71
Early research (Phase 1)UnknownNCT06256055
What this trial is testing

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Who this might be right for
Malignant MesotheliomaColorectal CancerBile Duct Cancer+4 more
UTC Therapeutics Inc. 24
Testing effectiveness (Phase 2)Study completedNCT05969184
What this trial is testing

Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC

Who this might be right for
Breast Neoplasm Female
Peking University Cancer Hospital & Institute 94
Testing effectiveness (Phase 2)Study completedNCT01618136
What this trial is testing

An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors

Who this might be right for
Malignant Solid TumourOvarian CancerTriple Negative Breast Cancer+2 more
Eisai Limited 41
Early research (Phase 1)Ended earlyNCT00088647
What this trial is testing

Study Evaluating MST-997 in Advanced Malignant Solid Tumors

Who this might be right for
Neoplasms
Wyeth is now a wholly owned subsidiary of Pfizer
Early research (Phase 1)Active Not RecruitingNCT02453620
What this trial is testing

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Breast Adenocarcinoma+2 more
National Cancer Institute (NCI) 57
Not applicableStudy completedNCT00974610
What this trial is testing

Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
Cancer Trials Ireland 803
Next Page